Cresco Labs Files 6-K, Reports March 12 News Release
Ticker: CRLBF · Form: 6-K · Filed: Mar 12, 2025 · CIK: 1832928
| Field | Detail |
|---|---|
| Company | Cresco Labs Inc. (CRLBF) |
| Form Type | 6-K |
| Filed Date | Mar 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, news-release, foreign-private-issuer
Related Tickers: CRLBF
TL;DR
Cresco Labs (CRLBF) filed a 6-K on 3/12, check the news release for updates.
AI Summary
Cresco Labs Inc. filed a Form 6-K on March 12, 2025, reporting a news release dated March 12, 2025. The filing indicates that Cresco Labs Inc. is a foreign private issuer and will file annual reports under Form 40-F. The principal executive offices are located at 600 W. Fulton Street, Suite 800, Chicago, IL 60661.
Why It Matters
This filing provides an update on Cresco Labs' reporting status and includes a news release, which may contain material information for investors.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that primarily serves to attach a news release, with no immediate financial or operational disclosures that would indicate high risk.
Key Players & Entities
- Cresco Labs Inc. (company) — Filer of the report
- Charles Bachtell (person) — Chief Executive Officer of Cresco Labs Inc.
- March 12, 2025 (date) — Date of the news release and filing
- 600 W. Fulton Street, Suite 800, Chicago, IL 60661 (location) — Principal executive offices of Cresco Labs Inc.
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is filed by foreign private issuers to report information that they have made or are required to make public in their home country, or that they have submitted or are required to submit to a stock exchange.
What is the significance of Cresco Labs filing under Form 40-F?
Filing under Form 40-F indicates that Cresco Labs Inc. is a foreign private issuer and will file its annual reports using this form, which is an alternative to Form 20-F for certain Canadian issuers.
Who signed the report on behalf of Cresco Labs Inc.?
The report was signed by Charles Bachtell, Chief Executive Officer of Cresco Labs Inc.
What is included as an exhibit in this 6-K filing?
Exhibit 99.1, a News Release dated March 12, 2025, is included in this 6-K filing.
What is the SIC code for Cresco Labs Inc.?
The Standard Industrial Classification (SIC) code for Cresco Labs Inc. is 2833, which corresponds to MEDICINAL CHEMICALS & BOTANICAL PRODUCTS.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 12, 2025 by Charles Bachtell regarding Cresco Labs Inc. (CRLBF).